A New Antibody For Treating Acute Lymphocytic Leukemia?

By /
as seen in Forbes

The new agent, a monoclonal antibody to CD22 with a toxin attached, is manufactured by Pfizer. It’s called inotuzumab ozogamicin.

Scroll to Top